期刊文献+

黄连解毒汤乙酸乙酯提取物对光滑念珠菌黏附作用的影响 被引量:6

Anti-attachment effect of ethyl acetate extract of Huanglian Jiedu decoction on Candida glabrata
原文传递
导出
摘要 目的:探讨黄连解毒汤乙酸乙酯提取物(ethyl acetate extract of Huanglian Jiedu decoction,EAHD)对光滑念珠菌Candida glabrata黏附作用的影响。方法:采用二倍稀释法测定黄连解毒汤乙酸乙酯提取物对光滑念珠菌的最低抑菌浓度(minimum inhibitory concentration,MIC);采用XTT还原法评价EAHD对光滑念珠菌黏附作用的影响;利用倒置显微镜、扫描电子显微镜与荧光显微镜观察EAHD对光滑念珠菌早期黏附形态学影响;采用半定量与实时荧光定量PCR检测其黏附相关基因EPA1,EPA6和EPA7的表达量。结果:EAHD对光滑念珠菌的MIC为320 mg·L-1,阳性对照药氟康唑对光滑念珠菌的MIC为1 mg·L-1;EAHD对光滑念珠菌2,4 h的黏附的干预作用较明显,其中对4 h效果优于2 h;PCR结果显示EAHD可显著抑制EPA1,EPA6和EPA7的表达。结论:EAHD可能通过抑制光滑念珠菌部分黏附基因的表达而抑制其早期黏附。 Objective: To investigate anti-attachment effect of ethyl acetate extract of Huanglian Jiedu decoction(EAHD) on Candida glabrata. Method: Serial 2-fold dilution assay was used to determine the minimum inhibitory concentrations MICs of EAHD to C. glabrata. XTF assay was used to evaluate the effect of EAHD against adhesion of C. glabrata. Inverted microscope, scanning electron microscope (SEM) and fluorescein diacetate (FDA) staining were applied to observe the morphological changes of C. glabrata in adhesion. PCR was adopted to inspect the expression of attachment-related genes such as EPA1, EPA6 and EPA7. Result: The MIC of EAHD and fluconazole to C. glabrata were 320 mg·L-1 and 1 mg·L-1 respectively. The total cells including budding ceils decreased in a dose-dependent manner following EAHD treatment. The expressions of EPAI, EPA6 and EPA7 were downregulated dra- matically after EAHD treatment. Conclusion: EAHD could effectively inhibit adherence of C. glabrata.
出处 《中国中药杂志》 CAS CSCD 北大核心 2015年第3期516-521,共6页 China Journal of Chinese Materia Medica
基金 国家自然科学基金项目(81073127) 安徽省自然科学基金项目(1408085MH165 1508085MH163)
关键词 黄连解毒汤乙酸乙酯提取物(EAHD) 光滑念珠菌 黏附 ethyl acetate extract of Huanglian Jiedu decoction (EAHD) Candida glabrata adhesion
  • 相关文献

参考文献10

  • 1Silva S, Negri M, Henriques M, et al. Candida glabrata, Can- dida parapsilosis and Candida tropicalis : biology, epidemiology, pathogenicity and antifungal resistance [ J ] . FEMS Microbiol Rev,2012,36(2) : 288.
  • 2Pankey G, Ashcraft D, Kahn H, et al. Time-kill assay and E test evaluation for synergy with polymyxin B and fluconazole against Candida glabrata [ J ]. Antimicrob Agents Chemother, 2014,58(10) :5795.
  • 3Wu J Q, Zhu L P, Ou X T, et al. Epidemiology and risk factors for non-Candida albicans candidemia in non-neutropenic patients at a Chinese teaching hospital[ J ]. Med Mycol, 2011, 49 ( 5 ) : 552.
  • 4Kaur R, Domergue R, Zupancic M L, et al. A yeast by any oth- er name: Candida glabrata and its interaction with the host[J[. Curt Opin Mierobiol, 2005, 8:378.
  • 5汪长中,程惠娟,徐颖,宋功道,官妍,王艳.黄连解毒汤及其单味药对体外白念珠菌生物膜影响的比较[J].上海中医药杂志,2008,42(2):63-65. 被引量:26
  • 6Li L, Redding S, Dongari A. Candida glabrata, an emerging oral opportunistic pathogen[ J]. J Dent Res, 2007,86 (3) :204.
  • 7De las Penas, A Pan, S Castano I, et al. Virulence-related sur- face glycoproteins in the yeast pathogen Candida glabrata are en- coded in subtelomeric clusters and subject to RAPl-and SIR-de- pendent transcriptional silencing [ J ] . Genes Dev, 2003, 17 : 2245.
  • 8Cormack B P, Ghori N, Falkow S. An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells[J]. Science, 1999,285:578.
  • 9Brul S King. The incorporation of manno proteins in the cell wall of S. cerevisiae and filamentous Ascomycetes [ J ]. Antonie Van Leeuwenhoek, 1997,72:229.
  • 10Iraqui I S, Garcia-Sanchez, S Aubert, et al. The Yaklp kinase controls expression of adhesins and biofilm formation in Candida glabrata in a Sirdp-dependent pathway [ J ]. Mol Microbiol, 2005, 55: 1259.

二级参考文献8

  • 1沈映君.中药药理学[M].北京:人民卫生出版社,2002.255-256.
  • 2Ramage JW, Walle KV, Wickes BL, etal. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms [J].Antinticrob Agents Chemother, 2001,45 (9) :2475-2479.
  • 3National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard. NCCLS document M27-A [J]. National Committee for Clinical Laboratory Standards, Wayne, Pennsylvania, USA. 1997.
  • 4Hawesr SP, Douglas LG. Biofilm formation by Candida species on the surface of catheter materials in vitro [J]. Infection and Immunity,1994,62 (3) : 915-921.
  • 5Bachmann SP, Vande Walle K, Ramage G, etal. In vitro activity of caspofungin against Candida albicans biofilms [J] .Antimicrob Agents Chemother, 2002,46 (11) : 3591-3596.
  • 6Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms [J] .Clin Microbiol Rev, 2002,15 (2) :167-193.
  • 7汪长中,程惠娟,官妍,汪本凡,王艳,汤华阳,乐红霞,宋功道.黄连解毒汤对体外白念珠菌生物膜形成的影响[J].热带病与寄生虫学,2007,5(2):82-84. 被引量:21
  • 8孙秋宁,Gordon Ramage,Jose L.Lopez-Ribot.念珠菌生物膜体外抗真菌药物敏感性研究[J].中华皮肤科杂志,2002,35(5):409-410. 被引量:9

共引文献25

同被引文献86

引证文献6

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部